NALIDIXIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nalidixic Acid, and when can generic versions of Nalidixic Acid launch?
Nalidixic Acid is a drug marketed by Sun Pharm Industries and Watson Labs and is included in six NDAs.
The generic ingredient in NALIDIXIC ACID is nalidixic acid. There are two drug master file entries for this compound. Additional details are available on the nalidixic acid profile page.
Summary for NALIDIXIC ACID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 133 |
Clinical Trials: | 6 |
Patent Applications: | 3,878 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NALIDIXIC ACID at DailyMed |
Recent Clinical Trials for NALIDIXIC ACID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Albany Medical College | N/A |
Alexandra Hospital, Athens, Greece | Phase 4 |
Hellenic Society of Gastroenterology | Phase 4 |